Indica Labs, a provider of computational pathology software and services, has announced that its HALO AP has received CE marking for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.
The HALO AP platform was developed by Indica Labs to address the specific needs of anatomic pathology laboratories by supporting a wide range of tissue-based workflows, including primary diagnosis, secondary consults, tumour boards, clinical trials, synoptic reporting, quantitative analytics, and artificial intelligence (AI).
Anatomic pathology is undergoing a major sea change as AI and computational tools become increasingly intertwined with routine digital workflows, and cloud-based technologies become the norm rather than the exception. Supporting image formats from all leading whole-slide scanner manufacturers, and with flexible deployment and integration options, HALO AP was built from the ground up to enable these emerging technologies and future-proof anatomic pathology laboratories moving forward.
HALO AP incorporates state-of-the-art workflow management tools allowing users to standardise reporting steps by defining tasks and dependances, including the ability to integrate quantitative analytics and AI tools built using HALO, HALO AI and third-party platforms. Tasks can be fully automated or delivered in a stepwise, guided fashion simplifying training and deployment. Integrated workflows are locked, secured and audited to prevent tampering or misuse.
With APIs to support connections to LIS/LIMS or other third-party systems, as well as flexible on-premise and cloud deployment options, HALO AP can integrate seamlessly within any organisation’s existing IT infrastructure. For laboratories without an existing LIS/LIMS, HALO AP can act as a fully functional, standalone case and image management system.
